About Sunmeck
Sunmeck is a Healthcare company. Pharmaceutical manufacturing, API production, and global supply based in India. The company has 1 employees. Its Indian entity Sunmeck Pharma Private Limited reported revenue of ₹2.36 Cr. Sunmeck offers products and services including Sildenafil Citrate and Other APIs and Intermediates. Its focus areas include Pharmaceuticals, Product Distribution, Global Export and API Manufacturing.
Company details
Sunmeck Pharmaceuticals is recognized as a fastest-growing company based in New Delhi, which was established in 2020 to focus on pharmaceutical sales and manufacturing. Its facilities are spread across Himachal Pradesh and Uttar Pradesh, where APIs like Sildenafil Citrate are produced for global markets including the United States and Europe. A strong emphasis is placed on RD and providing quality medications to meet societal needs, while integrity and excellence are maintained in operations to support continued growth in the specialty pharmaceutical sector.
- Employees 1
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Legal Name Sunmeck Pharma Private Limited
- Date of Incorporation 18 Apr, 2022
- Jurisdiction Delhi, India
- Indian entity revenue₹2.36 Cr
FY 2025 · +39% YoY
- Indian entity net profit₹3.2 Lakh
FY 2025 · 1% margin
- Indian entity EBITDA₹5.9 Lakh
FY 2025 · 2% margin
- Employee Count1
Associated legal entities of Sunmeck
Sunmeck operates through Sunmeck Pharma Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Sunmeck Pharma Private Limited CIN U33100DL2022PTC396760 | Active | 18 Apr 2022 | Delhi, Delhi | ₹2.4 Cr | 2 | View details |
Products & Services of Sunmeck
Sunmeck offers a comprehensive portfolio of products and services, including Sildenafil Citrate and Other APIs and Intermediates.
Production of active pharmaceutical ingredients is carried out for various therapeutic uses
Manufacturing of key APIs and intermediates is performed for global distribution
Board of directors of Sunmeck Pharma Private Limited (Sunmeck)
Sunmeck Pharma Private Limited is the primary company behind Sunmeck. The board of Sunmeck Pharma Private Limited currently have 2 directors; the longest-serving is Sanjeev Kumar Singh, appointed in 2022.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Sanjeev Kumar Singh DIN 09575059 | Director | 18 Apr 2022 | 4 yrs 6 mo | Sunmeck Pharma Private Limited |
| Arati Singh DIN 09575060 | Director | 18 Apr 2022 | 4 yrs 6 mo | Sunmeck Pharma Private Limited |
Financials of Sunmeck
Figures of Sunmeck Pharma Private Limited, the primary company behind Sunmeck, for FY 2025. Revenue was ₹2.36 Cr (+39% year on year). Net profit was ₹3.2 Lakh (1% margin). EBITDA was ₹5.9 Lakh (2% margin).
- ₹2.36 CrRevenue · FY 2025 · +39% YoY
- ₹3.2 LakhNet profit · 1% margin
- ₹5.9 LakhEBITDA · 2% margin
- ₹1 LakhPaid-up capital
Balance sheet, profit and loss, cash flow and ratios of Sunmeck Pharma Private Limited are on its company page.
Detailed financial statements for Sunmeck
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Sunmeck
Sunmeck has 1 employees.
The primary company behind Sunmeck, Sunmeck Pharma Private Limited, reported revenue of ₹2.36 Cr for FY 2025, up 39% year on year.
Sunmeck Pharmaceuticals is recognized as a fastest-growing company based in New Delhi, which was established in 2020 to focus on pharmaceutical sales and manufacturing. Its facilities are spread across Himachal Pradesh and Uttar Pradesh, where APIs like Sildenafil Citrate are produced for global markets including the United States and Europe. A strong emphasis is placed on RD and providing quality medications to meet societal needs, while integrity and excellence are maintained in operations to support continued growth in the specialty pharmaceutical sector.
Sunmeck offers Sildenafil Citrate and Other APIs and Intermediates.
Sunmeck operates through Sunmeck Pharma Private Limited.
The legal entities of Sunmeck currently have 2 directors, including Sanjeev Kumar Singh, Arati Singh.